Crossmark

Current and Emerging Therapies for Duchenne Muscular Dystrophy

Crossref DOI link: https://doi.org/10.1007/s11940-018-0513-6

Published Online: 2018-06-23

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Crone, Megan

Mah, Jean K.
License Information

Text and Data Mining valid from 2018-06-23
More Information

Article History

First Online: 23 June 2018

Compliance with Ethical Standards

:

: Megan Crone received a research grant from the Alberta Children’s Hospital Research Institute.Jean K. Mah received research support for DMD clinical trials from PTC Therapeutics, Pfizer, Bristol-Myers Squibb, RevereGen BioPharma, and NS Pharma.

: This article does not contain any studies with human or animal subjects performed by any of the authors.